These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

358 related items for PubMed ID: 6294284

  • 21. Discriminative stimulus effects of butorphanol: influence of training dose on the substitution patterns produced by Mu, Kappa and Delta opioid agonists.
    Picker MJ, Benyas S, Horwitz JA, Thompson K, Mathewson C, Smith MA.
    J Pharmacol Exp Ther; 1996 Dec; 279(3):1130-41. PubMed ID: 8968334
    [Abstract] [Full Text] [Related]

  • 22. Differential stereospecific effects of mu, kappa, and sigma opioid agonists on cortical EEG power spectra in the rat.
    Young GA, Khazan N.
    NIDA Res Monogr; 1983 Apr; 43():190-5. PubMed ID: 6308453
    [No Abstract] [Full Text] [Related]

  • 23. Comparison of the opioid activity of CAM and kappa agonists.
    Furst S, Friedmann T, Kovacs A, Wagner T.
    NIDA Res Monogr; 1986 Apr; 75():224-7. PubMed ID: 2828975
    [Abstract] [Full Text] [Related]

  • 24. In vivo studies on spinal opiate receptor systems mediating antinociception. II. Pharmacological profiles suggesting a differential association of mu, delta and kappa receptors with visceral chemical and cutaneous thermal stimuli in the rat.
    Schmauss C, Yaksh TL.
    J Pharmacol Exp Ther; 1984 Jan; 228(1):1-12. PubMed ID: 6319664
    [Abstract] [Full Text] [Related]

  • 25. In vivo binding of benzomorphans to mu, delta and kappa opioid receptors: comparison with urine output in the rat.
    Richards ML, Sadée W.
    J Pharmacol Exp Ther; 1985 May; 233(2):425-32. PubMed ID: 2987482
    [Abstract] [Full Text] [Related]

  • 26. Differential cross-tolerance to mu and kappa opioid agonists in morphine-tolerant rats responding under a schedule of food presentation.
    Picker MJ, Negus SS, Powell KR.
    Psychopharmacology (Berl); 1991 May; 103(1):129-35. PubMed ID: 1848712
    [Abstract] [Full Text] [Related]

  • 27. Antinociceptive profiles of mu and kappa opioid agonists in a rat tooth pulp stimulation procedure.
    Steinfels GF, Cook L.
    J Pharmacol Exp Ther; 1986 Jan; 236(1):111-7. PubMed ID: 2867210
    [Abstract] [Full Text] [Related]

  • 28. Differentiation between mu and kappa receptor-mediated effects in opioid drug discrimination: apparent pA2 analysis.
    Bertalmio AJ, Woods JH.
    J Pharmacol Exp Ther; 1987 Nov; 243(2):591-7. PubMed ID: 2824753
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Mu opiate isoreceptors: differentiation with kappa agonists.
    Wood PL, Richard JW, Thakur M.
    Life Sci; 1987 Nov; 31(20-21):2313-7. PubMed ID: 6131359
    [Abstract] [Full Text] [Related]

  • 31. The kappa opioid receptor, ingestive behaviors and the obese mouse (ob/ob).
    Morley JE, Levine AS, Gosnell BA, Kneip J, Grace M.
    Physiol Behav; 1983 Nov; 31(5):603-6. PubMed ID: 6320237
    [Abstract] [Full Text] [Related]

  • 32. Analgesic actions of mu- and kappa-opiate agonists in rats.
    Upton N, Sewell RD, Spencer PS.
    Arch Int Pharmacodyn Ther; 1983 Apr; 262(2):199-207. PubMed ID: 6135397
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Kappa opioid receptor activity in spontaneously hypertensive rats.
    Bhargava HN, Gulati A.
    J Pharmacol Exp Ther; 1988 May; 245(2):460-5. PubMed ID: 2835473
    [Abstract] [Full Text] [Related]

  • 35. Effects of opioid agonists selective for mu, kappa and delta opioid receptors on schedule-controlled responding in rhesus monkeys: antagonism by quadazocine.
    Negus SS, Burke TF, Medzihradsky F, Woods JH.
    J Pharmacol Exp Ther; 1993 Nov; 267(2):896-903. PubMed ID: 8246165
    [Abstract] [Full Text] [Related]

  • 36. Methocinnamox is a potent, long-lasting, and selective antagonist of morphine-mediated antinociception in the mouse: comparison with clocinnamox, beta-funaltrexamine, and beta-chlornaltrexamine.
    Broadbear JH, Sumpter TL, Burke TF, Husbands SM, Lewis JW, Woods JH, Traynor JR.
    J Pharmacol Exp Ther; 2000 Sep; 294(3):933-40. PubMed ID: 10945843
    [Abstract] [Full Text] [Related]

  • 37. Age-related differences in the sensitivity of serum luteinizing hormone to prototypic mu, kappa and delta opiate agonists and antagonists.
    Cicero TJ, Meyer ER, Miller BT, Bell RD.
    J Pharmacol Exp Ther; 1988 Jul; 246(1):14-20. PubMed ID: 2839658
    [Abstract] [Full Text] [Related]

  • 38. In vivo receptor binding of opioid drugs at the mu site.
    Rosenbaum JS, Holford NH, Sadée W.
    J Pharmacol Exp Ther; 1985 Jun; 233(3):735-40. PubMed ID: 2989495
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Functional effects of systemically administered agonists and antagonists of mu, delta, and kappa opioid receptor subtypes on body temperature in mice.
    Baker AK, Meert TF.
    J Pharmacol Exp Ther; 2002 Sep; 302(3):1253-64. PubMed ID: 12183687
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.